Kalaris Therapeutics KLRS
NASDAQ KLRS
$1.75 -0.15 (-7.89%)
As of: Nov 12, 2026 · 11:55 AM EST

Kalaris Therapeutics (KLRS) Net of Acquisitions & Divestments (2025)

Updated

Analysis

Kalaris Therapeutics (KLRS) Net of Acquisitions & Divestments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -887.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.15 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -10.59 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -630.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - 42.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Kalaris Therapeutics 44.52 Mn -38.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -102.11 Mn
API Access

Kalaris Therapeutics Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=KLRS&period=max&api_key=YOUR_API_KEY